October 23, 2020

Gene Editing Market to Reach at a US$ 9.2 Bn by 2026

According to the study carried out by Acumen Research & Consulting, the Gene Editing market will register a 15.3% CAGR in terms of revenue, the global market size is likely to reach US$ 9.2 Bn by 2026

This report also covers market opportunities and strategies, risk analysis, performance and decision making and industry assessment in the Global Gene Editing Market report. This report focuses on the market size, trends and projections from 2020-2027. The report includes facts and statistics on improvements in the business environment, technology advances, dynamics and innovations in economies, capabilities and knowledge on major players in the global Gene Editing market. The report contains information on the latest acquisitions and the study also covers the growth of the demand for Gene Editing in major regions globally.

Sample Report@  https://www.acumenresearchandconsulting.com/request-sample/1769

The market report on the Gene Editing also provides figures on demand and supply, revenues and future strategies, technological trends and growth rates. The Global Gene Editing Market report also provides 2016-2019 historical period and forecast period from 2020-2027 data together with market SWOT analysis data. The report also includes information by type, application, region and manufacturer or producer.

The epidemic has spread to almost 200 countries worldwide since the COVID-19 virus outbreak in December 2019, announcing it to have been a public health emergency by the World Health Organisation. The global implications of the 2019 coronavirus disease (COVID-19), which will impact the Gene Editing industry by 2020, are also being observed. The outbreak of COVID-19 affected a number of aspects, such as flight cancellation, travel prohibitions and quarantine, restaurants closed, indoor events restricted, state of emergency declared for over forty countries, massive slowing of supply chain, stock market volatility, reduced business confidence, increased public panic and future uncertainty.

Market Participants

Addgene, Allele Biotech, Bio-Rad, Caribou Biosciences, Inc., CRISPR Therapeutics, Dharmacon Inc., GE Healthcare, GeneCopoeia, Inc., GenScript Corporation, Horizon Discovery Group plc, Integrated DNA Technologies, OriGene Technologies, Merck Millipore Limited, Precision Biosciences, Sangamo Biosciences, Inc., Takara Bio, Agilent Technologies, Inc., and Thermo Fisher Scientific

Market Segmentation

Market By Technology

  • CRISPR
  • TALEN
  • ZFN
  • Other technologies

By Application

  • Cell line editing
  • Animal genome editing
  • Plant genome editing
  • Others

By End-user

  • Pharmaceutical & biotechnology companies
  • Academics and government research institutes
  • Clinical Research Organizations (CRO)

By Geography

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Gene Editing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Gene Editing Market By Technology
1.2.2.1. Global Gene Editing Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Gene Editing Market Revenue Share By Technology in 2018
1.2.2.3. CRISPR
1.2.2.4. TALEN
1.2.2.5. ZFN
1.2.2.6. Other technologies
1.2.3. Gene Editing Market By Application
1.2.3.1. Global Gene Editing Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Cell line editing
1.2.3.3. Animal genome editing
1.2.3.4. Plant genome editing
1.2.3.5. Others
1.2.4. Gene Editing Market By End-user
1.2.4.1. Global Gene Editing Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.4.2. Pharmaceutical & biotechnology companies
1.2.4.3. Academics and government research institutes
1.2.4.4. Clinical Research Organizations (CRO)
1.2.5. Gene Editing Market By Geography
1.2.5.1. Global Gene Editing Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Gene Editing Market Revenue and Growth Rate(2015-2026)
1.2.5.3. Europe Gene Editing Market Revenue and Growth Rate(2015-2026)
1.2.5.4. Asia-Pacific Gene Editing Market Revenue and Growth Rate(2015-2026)
1.2.5.5. Latin America Gene Editing Market Revenue and Growth Rate(2015-2026)
1.2.5.6. Middle East and Africa (MEA) Gene Editing Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Gene Editing Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Gene Editing Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Gene Editing Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Gene Editing Major Manufacturers in 2018

CHAPTER 4. GENE EDITING MARKET BY TECHNOLOGY
4.1. Global Gene Editing Revenue By Technology
4.2. CRISPR
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. TALEN
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. ZFN
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Other technologies
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. GENE EDITING MARKET BY APPLICATION
5.1. Global Gene Editing Revenue By Application
5.2. Cell line editing
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Animal genome editing
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Plant genome editing
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. GENE EDITING MARKET BY END-USER
6.1. Global Gene Editing Revenue By End-user
6.2. Pharmaceutical & biotechnology companies
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Academics and government research institutes
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Clinical Research Organizations (CRO)
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA GENE EDITING MARKET BY COUNTRY
7.1. North America Gene Editing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Gene Editing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Gene Editing Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE GENE EDITING MARKET BY COUNTRY
8.1. Europe Gene Editing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Gene Editing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC GENE EDITING MARKET BY COUNTRY
9.1. Asia-Pacific Gene Editing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Gene Editing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA GENE EDITING MARKET BY COUNTRY
10.1. Latin America Gene Editing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Gene Editing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA GENE EDITING MARKET BY COUNTRY
11.1. Middle East & Africa Gene Editing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East & Africa Gene Editing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Addgene
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Allele Biotech
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Bio-Rad
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Caribou Biosciences, Inc.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. CRISPR Therapeutics
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Dharmacon Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. GE Healthcare
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. GeneCopoeia, Inc.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. GenScript Corporation
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Horizon Discovery Group plc
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Integrated DNA Technologies
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Type Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Others
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Type Portfolio
12.12.5. Key Developments
12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Buy this premium report@ https://www.acumenresearchandconsulting.com/buy-now/0/1769

More Reports

Nasal Drug Delivery Devices Market Size Reach around US$ 78.3 Bn by 2027
Hydroxychloroquine Market Size Rising around US$ 6 Bn by 2027
Hand Sanitizer Market Size to Garner US$ 5 Bn by 2027


Contact Us:

Sheetal k

Email: sales@acumenresearchandconsulting.com

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

THOMAS ROBBINS

is a freelancer, a graduate of the University of Pennsylvania with a BA in English, he studied accounting at the Wharton School of Business, and currently lives in Staten Island has been covering business and technology for a variety of publications since 1989. He worked for Red Herring, Beyond Computing & Accounting Technolgy. He covers accounting, taxes, finance, government news & technology for the site Mail me

thomasrobbins@globepredict.com

View all posts by THOMAS ROBBINS →

Leave a Reply

Your email address will not be published. Required fields are marked *